Articles, App Notes, Case Studies, & White Papers

  1. Overcoming Obstacles To Deliver Critical Autologous Cell Therapy 3/25/2023

    See how teams ensured a seamless route, including on-time customs clearance and delivery of autologous cell therapy, from the U.S. to a manufacturing site in Germany

  2. Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It 3/9/2026

    Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.

  3. Transportation Solutions For Cell And Gene Therapy Supply Chains

    Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.

  4. Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics 7/21/2023

    By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.

  5. RTSM: Randomization And Cohort Management, IP Inventory Management 4/17/2024

    Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.

  6. Why RTSM Software Doesn't Belong Inside An All-In-One Suite 3/9/2026

    Don’t let administrative convenience compromise study integrity. Discover why purpose-built RTSM is essential for managing the technical complexities and specialized demands of modern trials.

  7. Choosing RTSM? Evaluate The Team Running It, Not Just The Software 2/25/2026

    High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.

  8. Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial 1/16/2024

    Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.

  9. How A Biotech Startup Transformed Their Clinical Trial Supply Management 2/25/2026

    Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.

  10. Top 5 Dos And Don'ts Of RTSM 7/16/2024

    Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.